Error: Could not add to watchlist. X

Cosmo Pharmaceuticals SA

+ Watchlist
CQ1:GR
Ticker Delisted
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cosmo Pharmaceuticals SA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.
ADDRESS
Via C Colombo 1
Lainate, 20020
Italy
PHONE
39-02-93337614
  • Mauro Severino Ajani
    Chairman/Founder
  • Alessandro Della Cha
    Chief Executive Officer
  • Hans Christoph Tanner
    CFO/Head:Investor Relations
  • Marco Lecchi
    Deputy Chief Financial Officer
  • Guiseppe Cipriano
    Chief Operating Officer
Show More